Used in the treatment of metabolic disorders such as type 2 diabetes and dyslipidemia by targeting and inhibiting the ANGPTL8 protein, which plays a role in regulating lipid metabolism and insulin sensitivity. This antibody helps lower triglyceride levels and improve glucose homeostasis by modulating lipoprotein lipase activity. It is also being investigated for potential use in reducing hepatic steatosis and improving cardiovascular risk profiles in patients with metabolic syndrome.